Tuttle RM - Search Results

1

Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.

Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, Brokhin M, Omry G, Fagin JA, Shaha A. Tuttle RM, et al. Thyroid. 2010 Dec;20(12):1341-9. doi: 10.1089/thy.2010.0178. Epub 2010 Oct 29. Thyroid. 2010. PMID: 21034228 Free PMC article.

2

Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease.

Tuttle RM, Patience T, Budd S. Tuttle RM, et al. Thyroid. 1995 Aug;5(4):243-7. doi: 10.1089/thy.1995.5.243. Thyroid. 1995. PMID: 7488862

3

Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma.

Robbins RJ, Tuttle RM, Sharaf RN, Larson SM, Robbins HK, Ghossein RA, Smith A, Drucker WD. Robbins RJ, et al. Among authors: tuttle rm. J Clin Endocrinol Metab. 2001 Feb;86(2):619-25. doi: 10.1210/jcem.86.2.7189. J Clin Endocrinol Metab. 2001. PMID: 11158019

4

Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin.

Robbins RJ, Tuttle RM, Sonenberg M, Shaha A, Sharaf R, Robbins H, Fleisher M, Larson SM. Robbins RJ, et al. Among authors: tuttle rm. Thyroid. 2001 Sep;11(9):865-9. doi: 10.1089/105072501316973127. Thyroid. 2001. PMID: 11575856

5

Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.

Tuttle RM, Fleisher M, Francis GL, Robbins RJ. Tuttle RM, et al. J Clin Endocrinol Metab. 2002 Apr;87(4):1737-42. doi: 10.1210/jcem.87.4.8388. J Clin Endocrinol Metab. 2002. PMID: 11932308

6

Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?

Robbins RJ, Chon JT, Fleisher M, Larson SM, Tuttle RM. Robbins RJ, et al. Among authors: tuttle rm. J Clin Endocrinol Metab. 2002 Jul;87(7):3242-7. doi: 10.1210/jcem.87.7.8702. J Clin Endocrinol Metab. 2002. PMID: 12107232

7

Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine.

Wang W, Larson SM, Tuttle RM, Kalaigian H, Kolbert K, Sonenberg M, Robbins RJ. Wang W, et al. Among authors: tuttle rm. Thyroid. 2001 Dec;11(12):1169-75. doi: 10.1089/10507250152741028. Thyroid. 2001. PMID: 12186505

8

A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation.

Robbins RJ, Larson SM, Sinha N, Shaha A, Divgi C, Pentlow KS, Ghossein R, Tuttle RM. Robbins RJ, et al. Among authors: tuttle rm. J Nucl Med. 2002 Nov;43(11):1482-8. J Nucl Med. 2002. PMID: 12411552 Free article.

9

Genome-wide appraisal of thyroid cancer progression.

Wreesmann VB, Ghossein RA, Patel SG, Harris CP, Schnaser EA, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. Wreesmann VB, et al. Among authors: tuttle rm. Am J Pathol. 2002 Nov;161(5):1549-56. doi: 10.1016/S0002-9440(10)64433-1. Am J Pathol. 2002. PMID: 12414503 Free PMC article.

10

Postoperative management of differentiated thyroid cancer.

Cohen EG, Tuttle RM, Kraus DH. Cohen EG, et al. Among authors: tuttle rm. Otolaryngol Clin North Am. 2003 Feb;36(1):129-57. doi: 10.1016/s0030-6665(02)00137-8. Otolaryngol Clin North Am. 2003. PMID: 12803014 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters